Member Info for 803799

In the Annual Report that was published on the 30th April it states that there equity holding in Vedanta was 35%, there's been no fundraise by Vedanta that i can see since then. So I don't see how they've been diluted down to 4%.

I'm emailing IR and if I don't get a satisfactory response I'll be referring PRTC to the FCA.

Market seems pretty nonplussed in the States. Down 2%

The most recent corporate presentation for PRTC dated August 2025 states that their equity holding in Vedanta is 35.8%….

I wouldn't have thought so panman. Short positions are disclosable. You can see them on various websites. Shorts here are only 0.6% I believe.

I imagine the market just sees this as more of the same from Puretech. Which, let's be honest, hasn't done a great deal for the share price in the last 5 years.

I’d be most interested to hear the Interim CEOs strategy at the half years. Especially around corporate strategy, if you go back to his appointment RNS the chair specifically mentions driving shareholder value. Maybe it’s just my interpretation but I take that to mean putting themselves up for sale. We’ll see.

The interesting thing about Invesco is that if an offer does come in the bidder could almost guarantee Invescos support at 17%. Whether that’s a good thing or not remains to be seen.

$BMY results tomorrow. Will make interesting reading on Cobenfy, personally looking for an acceleration of sales, and any comments on upcoming trials.

Thats an impressive red to blue day today. Not huge volume but plenty of buyers coming in

Also a bit of a cup and handle pattern forming on the chart. Can't be many stale bulls hanging about now. Big volume today, be good to see a breakout above 145 on high volume. Then we could be in business

Next BMS report is at the end of July. Would be good to see Cobenfy sales data and some colour on their trials for Alzeihmers. Alz alone could be worth $4bn annually according to one analyst.

Lol Punter you sad sack of sh**

Another 2 sales finalised and at a 10% premium too. Does make you wonder if they could achieve more than the 70p (after costs) originally forecast.

First profit warning of the year for me and it’s a grim one. Gonna see where it settles before deciding what to do.

Due news on Segilola end of Q2 as per Seguns most recent update. Any day now basically

Thanks. Most brokers actually have this form on their website

If you include the withheld votes the renumeration clause only got about 60% votes for

Bet the shorters had a torrid old time today

I would absolutely take £2 at this stage. Ridiculous considering the tender was at £2.50.

The only saving grace is that most Biotechs appear to be in a similar situation!

I was in Shanta and annoyingly it was taken over for a pitiful 13 or so % premium. Whoever bought that is absolutely laughing now. Had all the shareholders pants down, especially considering $3k gold now.

Seaport is worth a lot more than $325m

Anyone else having an issue with the audio on the webcast?